|
ACLX
|
Arcellx, Inc.
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
US
|
NYSE
|
|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CGEN
|
Compugen Ltd.
|
US
|
NASDAQ
|
|
CLLS
|
Cellectis S.A.
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
US
|
NASDAQ
|
|
NEXI
|
NexImmune, Inc.
|
US
|
NASDAQ
|
|
PSTV
|
Plus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
STRO
|
Sutro Biopharma, Inc.
|
US
|
NASDAQ
|
|
TSVT
|
2seventy bio, Inc.
|
US
|
NASDAQ
|
|
XOMA
|
XOMA Corporation
|
US
|
NASDAQ
|
|
XTLB
|
XTL Biopharmaceuticals Ltd.
|
US
|
NASDAQ
|
|
PAB
|
Patrys Limited
|
AU
|
ASX
|